Champions Oncology (CSBR) Selling, General & Administrative (2010 - 2026)
Champions Oncology (CSBR) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.13 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 216.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 593.21 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 347.92 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 247.47 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 161.89 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -196.26 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | 2.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.63 Mn |
| Jan 31, 2026 | 2.98 Mn |
| Oct 31, 2025 | 2.97 Mn |
| Jul 31, 2025 | 2.57 Mn |
| Apr 30, 2025 | 2.53 Mn |
| Jan 31, 2025 | 2.40 Mn |
| Oct 31, 2024 | 1.89 Mn |
| Jul 31, 2024 | 2.53 Mn |
| Apr 30, 2024 | 2.76 Mn |
| Jan 31, 2024 | 2.76 Mn |
| Oct 31, 2023 | 2.60 Mn |
| Jul 31, 2023 | 2.94 Mn |
| Apr 30, 2023 | 2.75 Mn |
| Jan 31, 2023 | 2.57 Mn |
| Oct 31, 2022 | 2.53 Mn |
| Jul 31, 2022 | 2.40 Mn |
| Apr 30, 2022 | 2.76 Mn |
| Jan 31, 2022 | 2.23 Mn |
| Oct 31, 2021 | 1.98 Mn |
| Jul 31, 2021 | 2.15 Mn |